The most important financial indicators for the company Mba Pharma Innovation Srl - Unique Identification Number 32413765:
sales in 2023 was
4.467.618
euro, registering a net profit of
981.130
euro and having an average number of
10
employees.
Firma isi desfasoara activitatea in domeniul Comert cu ridicata al produselor farmaceutice having the NACE code 4646.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 43.6%, from 3.120.709 euro in the year 2022, to 4.467.618 euro in 2023.
The Net Profit increased by 216.665 euro, from 766.791 euro in 2022, to 981.130 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Mba Pharma Innovation Srl - CUI 32413765
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
-
50
484
81.355
94.646
38.796
154.200
279.318
268.470
309.098
Current Assets
-
18.804
46.482
130.398
439.384
426.398
1.146.161
1.137.434
2.228.940
2.785.679
Inventories
-
9.325
3.505
42.588
91.974
134.619
42.395
76.677
328.177
824.082
Receivables
-
1.630
6.858
14.386
68.451
65.031
438.231
556.562
1.329.626
1.652.788
Cash
-
7.849
36.119
73.424
278.960
226.748
665.535
504.195
571.138
308.809
Shareholders Funds
-
6.626
40.359
47.495
250.578
250.328
897.038
1.189.629
1.732.046
1.851.010
Social Capital
-
45
45
44
43
42
41
40
41
40
Debts
-
12.229
6.608
164.259
283.411
214.479
402.955
226.762
383.780
1.243.768
Income in Advance
-
0
0
0
41
388
369
361
381.585
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
2.785.679 euro in 2023 which includes Inventories of
824.082 euro, Receivables of
1.652.788 euro and cash availability of
308.809 euro.
The company's Equity was valued at
1.851.010 euro, while total Liabilities amounted to
1.243.768 euro.
Equity increased by 124.216 euro, from 1.732.046 euro in 2022, to 1.851.010 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Mba Pharma Innovation Srl